Supplementary Figure 5 from Resistance to Selective FGFR Inhibitors in <i>FGFR-</i>Driven Urothelial Cancer

<p>Synergic effect of gefitinib and erdafitinib in MR15 cell line.</p>

保存先:

書誌詳細
第一著者:	Francesco Facchinetti (16827090) (author)
その他の著者:	Antoine Hollebecque (15010338) (author), Floriane Braye (16827093) (author), Damien Vasseur (16827096) (author), Yoann Pradat (15352227) (author), Rastislav Bahleda (16617234) (author), Cédric Pobel (16617263) (author), Ludovic Bigot (16617254) (author), Olivier Déas (16827099) (author), Juan David Florez Arango (16827102) (author), Giorgia Guaitoli (16827105) (author), Hayato Mizuta (16827108) (author), David Combarel (16827111) (author), Lambros Tselikas (15019536) (author), Stefan Michiels (9081965) (author), Sergey I. Nikolaev (15061686) (author), Jean-Yves Scoazec (15036392) (author), Santiago Ponce-Aix (16827114) (author), Benjamin Besse (15061674) (author), Ken A. Olaussen (16827117) (author), Yohann Loriot (15123021) (author), Luc Friboulet (15025943) (author)
出版事項:	2025
主題:	Cancer Therapeutic Research and Development Drug Resistance Clinical drug resistance Reversal of drug resistance Drug Targets Protein kinase & phosphatase drug targets Genitourinary Cancers Bladder cancer
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料